Adaptive Biotechnologies Executive Sells Shares Amid Strategic Shift and Financial Expansion
Adaptive Biotechnologies Corp (NASDAQ: ADPT) Chief Commercial Officer Susan Bobulsky executed a stock sale on July 1, 2026, disposing of 487 shares at $22.00 each under a pre-existing Rule 10b5-1 plan. The transaction follows a period of significant price appreciation for ADPT, which recently traded near its 52-week high of $22.80. This insider act…